Award
Delivery Order #SPE2DR26F9TM1
Short-Term Delivery Order for Chemotherapy Drug by AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$667.60
Ceiling
$667.60
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2DR26F9TM1
NAICS
424210
This recent contract award is a delivery order under an existing indefinite delivery vehicle agreement with AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The delivery order specifically procures vials of Cisplatin, a chemotherapy medication critical for cancer treatment. The award exemplifies the agency's ongoing efforts to maintain reliable access to essential pharmaceuticals required for patient care. The scope involves timely delivery of specified medication to a designated location, ensuring continuity of supply for healthcare providers. This contract was awarded competitively as part of the broader established vehicle, leveraging AmerisourceBergen's extensive distribution capabilities. The performance period is brief, spanning a couple of days, reflecting the nature of timely pharmaceutical deliveries. It supports the agency's long-term pharmaceutical supply chain under the parent contract, solidifying critical healthcare resource availability.
Description
4571003373!CISPLATIN 100 MG/100 ML VIAL 100ML